Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Merck KGaA appoints new head of pharma

December 17, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Elmar Schnee, Merck KGaA, Merck Serono, Stefan Oschmann, appoinment, manufacturing and production, research and development, sales and marketing

Merck KGaA has appointed Stefan Oschmann head of its pharmaceuticals division Merck Serono. He takes office on 1 January 2011 …
Appointment

Novartis becomes global eye health leader as Alcon deal finalised

December 15, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Alcon, Lucentis, Novartis, eye care, eye health, ophthalmology

Novartis’ 11-month standoff with Alcon shareholders has ended, allowing it to acquire all the remaining shares in the ophthalmology firm. …
News

Patient deaths halt Lilly cancer trial

December 15, 2010 Research and Development Eli Lilly, lilly, melanoma, skin cancer, tasisulam

Lilly has been forced to halt phase III trials of its melanoma candidate tasisulam due to serious safety concerns over …
News

Sanofi-Aventis appoints Dr Elias Zerhouni head of R&D

December 15, 2010 Research and Development Dr Elias Zerhouni, Sanofi-Aventis, appointment, research and development

Dr Elias Zerhouni has been appointed president of global research and development at Sanofi-Aventis with effect from 1 January 2011. …
Appointment

Sanofi extends Genzyme share deal deadline

December 14, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Genzyme, Sanofi, Sanofi-Aventis, mergers and acquisitions, pharma acquisitions

Sanofi-Aventis has extended the deadline to acquire Genzyme after the US biotech’s shareholders have so far proved immune to its …
News
Amgen HQ

Amgen and Actelion meet to “talk takeover”

December 13, 2010 Research and Development, Sales and Marketing Acelion, Amgen, pharma acquisitions, takeover

Amgen has met with Actelion to discuss a potential takeover but has not yet made a bid for the Swiss …
News

Novartis pulls Zometa submission after breast cancer failure

December 13, 2010 Research and Development, Sales and Marketing Novatis, Zometa, breast cancer, zoledronic

Novartis has pulled Zometa’s marketing application for an early breast cancer indication after the drug failed to meet its primary …
News

China to ‘overtake US in innovation by 2020’

December 13, 2010 Research and Development, Sales and Marketing AstraZeneca, China, India, innovation

China will replace the US as the number one ‘powerhouse of innovation’ within the next ten years according to a …
News

Bristol-Myers Squibb appoints new UK general manager

December 13, 2010 Manufacturing and Production, Research and Development, Sales and Marketing Amadou Diarra, BMS, Bristol-Myers Squibb, appointment, recruitment, sales and marketing

Bristol-Myers Squibb has appointed Amadou Diarra as general manager of its UK company, where he will be in charge of …
News

Pfizer: WikiLeaks claims “preposterous”

December 10, 2010 Research and Development Nigeria, Pfizer, Trovan, WikiLeaks, ceftriaxone, clinical trial safety, industry reputation

Pfizer has dimissed as “preposterous” the claims it hired investigators to uncover evidence of corruption by a top government official …
News

Hormone therapy drugs ‘increase heart disease risk’

December 10, 2010 Research and Development AstraZeneca, Hormone therapy, Novartis, Pfizer, aromatase inhibitors, breast cancer, tamoxifen

Three aromatase inhibitors could increase the risk of heart disease in postmenopausal women with breast cancer, according to new data. …
News

Elan names Robert Ingram as new chairman

December 10, 2010 Research and Development, Sales and Marketing Elan, appointment, research and development, sales and marketing

Elan has appointed former Glaxo Wellcome chief executive Robert Ingram as its chairman-designate. Ingram led Glaxo between 1997 and 2000 …
Appointment

Boehringer puts afatinib head-to-head with Herceptin

December 10, 2010 Research and Development BIBW 2992, Boehringer Ingelheim, Herceptin, Roche, Tovok, afatinib, breast cancer

Boehringer Ingelheim has set up a showdown between one of its pipeline oncology products and Roche’s Herceptin. It has started …
News

Roche highlights R&D promise after setbacks

December 9, 2010 Research and Development MS, Roche, oncology, personalised medicine, schizophrenia

Roche has presented its pipeline to shareholders to boost confidence that it can sustain the spectacular growth of recent years. …
News

William Vickery joins Hybrigenics

December 8, 2010 Research and Development Hybrigenics, William Vickery, appointment, research and development

Paris-based biopharmaceutical company Hybrigenics has appointed William Vickery to the newly-created position of head of corporate and business development. He …
Appointment
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026